Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST

Artelo Biosciences (ARTL) Receivables - Other (2015 - 2020)

Updated

Artelo Biosciences' Receivables - Other was $16,484 in Q3 2018.

Analysis

Artelo Biosciences (ARTL) Receivables - Other (2015 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Artelo Biosciences 49.32 Mn 32.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 29, 2020 29,558.00
Nov 30, 2019 45,587.00
Aug 31, 2019 8,787.00
May 31, 2019 6,942.00
Feb 28, 2019 8,951.00
Nov 30, 2018 3,462.00
Aug 31, 2018 22,127.00
May 31, 2018 16,484.00
Feb 28, 2018 1,327.00
Nov 30, 2017 767.00
Aug 31, 2016 600.00
Aug 31, 2015 -600.00
API Access

Artelo Biosciences Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ARTL&period=max&api_key=YOUR_API_KEY